Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-010196
Filing Date
2020-08-10
Accepted
2020-08-10 16:17:20
Documents
89
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q neos-20200630x10q.htm   iXBRL 10-Q 2896003
2 EX-10.4 neos-20200630xex10d4.htm EX-10.4 20295
3 EX-10.5 neos-20200630xex10d5.htm EX-10.5 21308
4 EX-10.6 neos-20200630xex10d6.htm EX-10.6 21344
5 EX-10.7 neos-20200630xex10d7.htm EX-10.7 22043
6 EX-10.8 neos-20200630xex10d8.htm EX-10.8 20719
7 EX-10.9 neos-20200630xex10d9.htm EX-10.9 20255
8 EX-31.1 neos-20200630xex31d1.htm EX-31.1 12282
9 EX-31.2 neos-20200630xex31d2.htm EX-31.2 12822
10 EX-32.1 neos-20200630xex32d1.htm EX-32.1 8777
11 GRAPHIC neos-20200630x10q001.jpg GRAPHIC 633
  Complete submission text file 0001558370-20-010196.txt   11113467

Data Files

Seq Description Document Type Size
12 EX-101.SCH neos-20200630.xsd EX-101.SCH 73973
13 EX-101.CAL neos-20200630_cal.xml EX-101.CAL 72627
14 EX-101.DEF neos-20200630_def.xml EX-101.DEF 318846
15 EX-101.LAB neos-20200630_lab.xml EX-101.LAB 717038
16 EX-101.PRE neos-20200630_pre.xml EX-101.PRE 566883
17 EXTRACTED XBRL INSTANCE DOCUMENT neos-20200630x10q_htm.xml XML 1873100
Mailing Address 2940 N. HIGHWAY 360 SUITE 400 GRAND PRAIRIE TX 75050
Business Address 2940 N. HIGHWAY 360 SUITE 400 GRAND PRAIRIE TX 75050 972.408.1360
Neos Therapeutics, Inc. (Filer) CIK: 0001467652 (see all company filings)

EIN.: 270395455 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37508 | Film No.: 201089602
SIC: 2834 Pharmaceutical Preparations